NORHA is a novel index for quantifying hippocampal asymmetries in neurodegenerative conditions. It shows promise as a biomarker for detecting unilateral abnormalities, such as hippocampal sclerosis, and correlates positively with the functional cognitive test CDR-SB, indicating its potential in dementia diagnosis.